Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00343629 · ClinicalTrials.gov registry record · NA
Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT00343629: Completed NA study, sponsored by Mayo Clinic.
NCT00343629 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00343629, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
RATIONALE: Giving healthy volunteers sulindac capsules or sulindac tablets may help doctors learn which form of the drug may be more effective in preventing cancer. PURPOSE: This randomized clinical trial is studying sulindac capsules to see how well they work compared with sulindac tablets in healthy volunteers.
Interventions
- OTHER pharmacological study
- DRUG sulindac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00343629
The ClinicalTrials.gov registry entry for NCT00343629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which pharmacological study is the first listed.
NCT00343629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00343629 about?
NCT00343629 is a clinical study titled "Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers". RATIONALE: Giving healthy volunteers sulindac capsules or sulindac tablets may help doctors learn which form of the drug may be more effective in preventing cancer. PURPOSE: This randomized clinical trial is studying sulindac capsules to see how well they work compared with sulindac tablets in heal...
What is the current status of trial NCT00343629?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2006-04. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00343629?
The interventions under investigation include: pharmacological study (OTHER), sulindac (DRUG).
Who is sponsoring clinical trial NCT00343629?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.